Safety and feasibility of concomitant scalp cooling and limb cryocompression to prevent paclitaxel-induced alopecia and neuropathy.
Bandla A, Wong R, Santhanakrishnan P, Magarajah G, Yee YE, Ng WY, Ow S, Chan G, Choo J, Lim SE, Wong A, Vijayan J, Paxman R, Lee YM, Hui F, Hairom Z, Ang E, Loprinzi C, Thakor N, Lee SC, Kumarakulasinghe N, Lim J, Sundar R.
Bandla A, et al. Among authors: hui f.
Support Care Cancer. 2025 Feb 12;33(3):180. doi: 10.1007/s00520-024-08982-6.
Support Care Cancer. 2025.
PMID: 39937296
Free PMC article.
Limb cryocompression was administered starting at 11 C, with thermoregulation allowed up to 25 C to accommodate patient tolerance. Core body temperature changes, adverse events (CTCAE v4.0), and tolerance to cryotherapy were documented. ...Eight patients completed a …
Limb cryocompression was administered starting at 11 C, with thermoregulation allowed up to 25 C to accommodate patient tolera …